VERTEX PHARMACEUTICALS INC / MA 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Oct 3, 2014
Insider Transaction Report
Form 4
Connolly Thomas
SVP, Human Resources
Transactions
- Sale
Common Stock
2014-10-01$107.28/sh−450$48,276→ 15,195 total - Sale
Common Stock
2014-10-01$108.30/sh−200$21,660→ 14,995 total - Sale
Common Stock
2014-10-01$111.52/sh−100$11,152→ 14,895 total
Holdings
- 150(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]Transaction made pursuant to Mr. Connolly's company approved trading plan under Rule 10b5-1.
- [F2]Open market sales reported on this line occurred at a weighted average price of $107.28 (range $106.92 to $107.84).
- [F3]Mr. Connolly undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- [F4]Open market sales reported on this line occurred at a weighted average price of $108.30 (range $108.06 to $108.54).